Search for: "ETHYPHARM S.A." Results 1 - 8 of 8
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Court Report
8 Aug 2010, 8:32 pm by Patent Docs
• Defendants: Ranbaxy Laboratories Ltd.; Ranbaxy Pharmaceuticals Inc.; Ranbaxy, Inc.; Ethypharm S.A. [read post]
Patent Docs - http://www.patentdocs.org/
Magistrate Judge Thynge: Decision regarding a party's obligation to produce witnesses of its foreign affiliate for depositions
24 Nov 2010, 6:53 am by Pilar G. Kraman
Ethypharm S.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Judge Thynge: Motion of issuance of letters rogatory for discovery into prosecution of an unrelated patent DENIED
5 Nov 2010, 11:55 am by Pilar G. Kraman
Ethypharm S.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Motion to Disqualify Based on Joint Defense Agreement Denied Where Agreement Did Not Create Implied Attorney-Client Relationship
23 Jan 2019, 6:12 pm by Stan Gibson
Takeda moved to disqualify Baker Botts from representing Zydus based on Baker Botts’ alleged previous representation of Ethypharm S.A. [read post]
Patent Lawyer Blog - http://patentlaw.jmbm.com/
NJ District Court Declines to Exercise Declaratory Judgment Jurisdiction in Feud Over Generic ANTARA; Lupin is Given Another Bite at the Apple
20 Jan 2011, 1:03 pm by Hyman, Phelps & McNamara, P.C.
Patent No. 7,101,574 ("the ‘574 patent") covering ANTARA (fenofibrate) Capsules, which is approved under NDA No. 21-695, and granted a Motion to Dismiss filed by defendants Ethypharm S.A., Lupin Limited, and Lupin Pharmaceuticals, Inc. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Digest for January 31, 2011
31 Jan 2011, 10:25 am by Ted Folkman
Ethypharm S.A. [read post]
Letters Blogatory - http://lettersblogatory.com/
The Cat, the Sister and the 4th Amendment
17 Jan 2014, 2:43 pm
’ Ethypharm S.A. [read post]
CYB3RCRIM3 - http://cyb3rcrim3.blogspot.com/
Pharma & Biotech Global Week in Review 15 June 2011 from IP Think Tank
15 Jun 2011, 4:56 am by Marie Louise
(Patent Docs) Treximet (Sumatriptan, Naproxen) – US: patent infringement complaint filed against Mylan, Ethypharm in response to Para IV certification: Pozen Inc. v. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog